ResMed | RMD - Net Income


ResMed reported $392.59M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Ansell USD 23.3M 33.8M Jun/2025
Artivion USD -2.29M 167K Sep/2024
AtriCure USD 1.76M 2.02M Dec/2025
Baxter International USD -1.13B 1.08B Dec/2025
Cochlear AUD 91.9M 113.2M Jun/2025
Cooper Companies USD 84.6M 13.7M Sep/2025
CSL USD 497.5M 1.51B Jun/2025
Dexcom USD 267.3M 16.5M Dec/2025
Edwards Lifesciences USD 91.2M 199.9M Dec/2025
Fisher Paykel Healthcare NZD 213M 11M Dec/2025
Globus Medical USD 140.59M 21.63M Dec/2025
Haemonetics USD 44.74M 6.06M Dec/2025
Hologic USD 179.1M 8.2M Dec/2025
Idexx Laboratories USD 248.19M 26.42M Dec/2025
Inogen USD -5.96M 373K Sep/2024
Insulet USD 101.6M 14M Dec/2025
Integra LifeSciences USD -5.4M 478.67M Sep/2025
Intuitive Surgical USD 794.8M 90.4M Dec/2025
Masimo USD -100.4M 151.7M Sep/2025
Medtronic USD 1.14B 231M Dec/2025
Philips EUR 395M 211M Dec/2025
Ramsay Health Care AUD 120.3M 225.2M Jun/2025
ResMed USD 392.59M 44.06M Dec/2025
Sigma Healthcare AUD -6.72M 10.02M Dec/2024
Sonic Healthcare AUD 236.68M 82.29M Dec/2024
Steris USD 192.9M 1000K Dec/2025
Teleflex USD -408.89M 531.47M Sep/2025
Thermo Fisher Scientific USD 1.96B 348M Dec/2025